Vaidya Sane Ayurved Laboratories Ltd Financials
Company Logo

Vaidya Sane Ayurved Laboratories Ltd Financial Statement

Vaidya Sane Ayurved Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Vaidya Sane Ayurved Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual97.33
Operating Expenses Annual94.16
Operating Profit Annual4.73
Interest Annual0.25
Depreciation2.13
Net Profit Annual1.05
Tax Annual0.41

Vaidya Sane Ayurved Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning1.75
Cash Flow from Operations-3.11
Cash Flow from Investing0.02
Cash Flow from Financing14.46
Cash Flow at the End13.12

Vaidya Sane Ayurved Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)5.53
PBIT Margin (%)2.41
PBT Margin (%)0.22
Net PROFIT Margin (%)1.08
Return On Networth / Equity (%)1.88
Return On Networth /Employed (%)4.70
Return On Assets (%)2.09
Total Debt / Equity (X)0.02
Asset Turnover Ratio (%)1.94

Vaidya Sane Ayurved Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual22.08
Total Current Assets Annual32.20
Non Current Assets Annual39.20
Total Shareholders Funds Annual55.02
Total Assets Annual71.39

Vaidya Sane Ayurved Laboratories Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 19, 2024, Vaidya Sane Ayurved Laboratories Ltd has a market capitalization of 182.93 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Vaidya Sane Ayurved Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.03.
In FY 2023 , Vaidya Sane Ayurved Laboratories Ltd recorded a total revenue of approximately 97.33 Cr marking a significant milestone in the company's financial performance.
Vaidya Sane Ayurved Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.1% annually, respectively..
Vaidya Sane Ayurved Laboratories Ltd's current PE ratio is 174.22.
Vaidya Sane Ayurved Laboratories Ltd's ROCE averaged 11.2% from the FY ending March 2022 to 2024, with a median of 13.4%. It peaked at 17.3% in March 2023, reflecting strong capital efficiency over the period..
Vaidya Sane Ayurved Laboratories Ltd's latest EBIT is Rs. 1.70 Cr, surpassing the average EBIT of Rs. 4.58 Cr over the 5 years..